annual cash & cash equivalents:
$7.97B+$688.00M(+9.45%)Summary
- As of today (September 8, 2025), ABT annual cash & cash equivalents is $7.97 billion, with the most recent change of +$688.00 million (+9.45%) on December 31, 2024.
- During the last 3 years, ABT annual cash & cash equivalents has fallen by -$2.28 billion (-22.27%).
- ABT annual cash & cash equivalents is now -57.57% below its all-time high of $18.77 billion, reached on December 31, 2016.
Performance
ABT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$7.28B+$438.00M(+6.40%)Summary
- As of today (September 8, 2025), ABT quarterly cash & cash equivalents is $7.28 billion, with the most recent change of +$438.00 million (+6.40%) on June 30, 2025.
- Over the past year, ABT quarterly cash & cash equivalents has increased by +$63.00 million (+0.87%).
- ABT quarterly cash & cash equivalents is now -61.21% below its all-time high of $18.77 billion, reached on December 31, 2016.
Performance
ABT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ABT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.4% | +0.9% |
| 3 y3 years | -22.3% | -21.6% |
| 5 y5 years | +92.4% | +44.6% |
ABT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.3% | +9.4% | -28.4% | +9.5% |
| 5 y | 5-year | -22.3% | +92.4% | -28.9% | +53.9% |
| alltime | all time | -57.6% | +6372.8% | -61.2% | >+9999.0% |
ABT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $7.28B(+6.4%) |
| Mar 2025 | - | $6.84B(-14.1%) |
| Dec 2024 | $7.97B(+9.5%) | $7.97B(+2.3%) |
| Sep 2024 | - | $7.79B(+7.9%) |
| Jun 2024 | - | $7.22B(+8.5%) |
| Mar 2024 | - | $6.65B(-8.6%) |
| Dec 2023 | $7.28B(-28.4%) | $7.28B(+3.3%) |
| Sep 2023 | - | $7.05B(-13.6%) |
| Jun 2023 | - | $8.15B(-14.4%) |
| Mar 2023 | - | $9.53B(-6.3%) |
| Dec 2022 | $10.17B(-0.8%) | $10.17B(+2.7%) |
| Sep 2022 | - | $9.91B(+6.6%) |
| Jun 2022 | - | $9.29B(+13.9%) |
| Mar 2022 | - | $8.16B(-20.4%) |
| Dec 2021 | $10.25B(+43.4%) | $10.25B(+5.7%) |
| Sep 2021 | - | $9.69B(+8.4%) |
| Jun 2021 | - | $8.94B(+6.8%) |
| Mar 2021 | - | $8.37B(+17.1%) |
| Dec 2020 | $7.15B(+72.7%) | $7.15B(+51.1%) |
| Sep 2020 | - | $4.73B(-6.1%) |
| Jun 2020 | - | $5.04B(+37.3%) |
| Mar 2020 | - | $3.67B(-11.4%) |
| Dec 2019 | $4.14B(+1.3%) | $4.14B(-4.5%) |
| Sep 2019 | - | $4.33B(+28.4%) |
| Jun 2019 | - | $3.38B(+3.5%) |
| Mar 2019 | - | $3.26B(-20.2%) |
| Dec 2018 | $4.09B(-57.5%) | $4.09B(-45.9%) |
| Sep 2018 | - | $7.55B(+131.3%) |
| Jun 2018 | - | $3.26B(-19.2%) |
| Mar 2018 | - | $4.04B(-57.9%) |
| Dec 2017 | $9.61B(-48.8%) | $9.61B(-14.2%) |
| Sep 2017 | - | $11.20B(+13.9%) |
| Jun 2017 | - | $9.84B(+11.0%) |
| Mar 2017 | - | $8.86B(-52.8%) |
| Dec 2016 | $18.77B(+206.5%) | $18.77B(+316.6%) |
| Sep 2016 | - | $4.51B(+1.6%) |
| Jun 2016 | - | $4.44B(+12.2%) |
| Mar 2016 | - | $3.96B(-35.4%) |
| Dec 2015 | $6.13B(+37.3%) | $6.13B(-0.2%) |
| Sep 2015 | - | $6.14B(-45.1%) |
| Jun 2015 | - | $11.18B(+13.5%) |
| Mar 2015 | - | $9.85B(+120.8%) |
| Dec 2014 | $4.46B(-44.9%) | $4.46B(-8.6%) |
| Sep 2014 | - | $4.88B(-30.9%) |
| Jun 2014 | - | $7.06B(+0.2%) |
| Mar 2014 | - | $7.05B(-13.0%) |
| Dec 2013 | $8.10B(-46.6%) | $8.10B(-5.9%) |
| Sep 2013 | - | $8.61B(-8.4%) |
| Jun 2013 | - | $9.39B(+10.3%) |
| Mar 2013 | - | $8.52B(-43.9%) |
| Dec 2012 | $15.17B(+87.4%) | $15.17B(+31.9%) |
| Sep 2012 | - | $11.50B(+4.6%) |
| Jun 2012 | - | $11.00B(+15.5%) |
| Mar 2012 | - | $9.53B(+17.7%) |
| Dec 2011 | $8.10B(+10.6%) | $8.10B(+1.5%) |
| Sep 2011 | - | $7.98B(-10.3%) |
| Jun 2011 | - | $8.89B(+6.2%) |
| Mar 2011 | - | $8.38B(+14.4%) |
| Dec 2010 | $7.32B(-26.3%) | $7.32B(+28.0%) |
| Sep 2010 | - | $5.72B(-8.4%) |
| Jun 2010 | - | $6.24B(+69.1%) |
| Mar 2010 | - | $3.69B(-62.8%) |
| Dec 2009 | $9.93B(+95.5%) | $9.93B(+14.2%) |
| Sep 2009 | - | $8.70B(+26.2%) |
| Jun 2009 | - | $6.89B(+20.8%) |
| Mar 2009 | - | $5.70B(+12.3%) |
| Dec 2008 | $5.08B | $5.08B(+34.9%) |
| Sep 2008 | - | $3.77B(-27.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | - | $5.18B(+42.4%) |
| Mar 2008 | - | $3.64B(+28.9%) |
| Dec 2007 | $2.82B(+105.4%) | $2.82B(+10.7%) |
| Sep 2007 | - | $2.55B(+13.9%) |
| Jun 2007 | - | $2.24B(+36.3%) |
| Mar 2007 | - | $1.64B(+19.5%) |
| Dec 2006 | $1.37B(-53.5%) | $1.37B(+30.7%) |
| Sep 2006 | - | $1.05B(-4.2%) |
| Jun 2006 | - | $1.10B(-54.4%) |
| Mar 2006 | - | $2.40B(-18.7%) |
| Dec 2005 | $2.96B(+43.6%) | $2.96B(+1.0%) |
| Sep 2005 | - | $2.93B(+90.8%) |
| Jun 2005 | - | $1.53B(-15.4%) |
| Mar 2005 | - | $1.81B(-11.9%) |
| Dec 2004 | $2.06B(+60.1%) | $2.06B(+60.1%) |
| Dec 2003 | $1.29B(+33.2%) | $1.29B(+33.2%) |
| Dec 2002 | $966.13M(-16.5%) | $966.13M(-16.5%) |
| Dec 2000 | $1.16B(+59.9%) | $1.16B(+19.5%) |
| Sep 2000 | - | $967.64M(-1.7%) |
| Jun 2000 | - | $984.25M(+26.9%) |
| Mar 2000 | - | $775.35M(+7.2%) |
| Dec 1999 | $723.30M(+88.7%) | $723.30M(+14.7%) |
| Sep 1999 | - | $630.38M(+56.9%) |
| Jun 1999 | - | $401.75M(+1.2%) |
| Mar 1999 | - | $396.81M(+3.5%) |
| Dec 1998 | $383.32M(+48.0%) | $383.32M(+39.9%) |
| Sep 1998 | - | $274.03M(-15.2%) |
| Jun 1998 | - | $323.01M(+9.5%) |
| Mar 1998 | - | $294.94M(+13.9%) |
| Dec 1997 | $259.01M(+110.4%) | $259.01M(+56.4%) |
| Sep 1997 | - | $165.58M(+14.0%) |
| Jun 1997 | - | $145.19M(-4.6%) |
| Mar 1997 | - | $152.23M(+23.7%) |
| Dec 1996 | $123.08M(-61.0%) | $123.08M(-31.3%) |
| Sep 1996 | - | $179.17M(+0.8%) |
| Jun 1996 | - | $177.67M(+34.6%) |
| Mar 1996 | - | $131.96M(-58.2%) |
| Dec 1995 | $315.70M(+0.1%) | $315.70M(-23.9%) |
| Sep 1995 | - | $414.67M(+33.4%) |
| Jun 1995 | - | $310.86M(+24.3%) |
| Mar 1995 | - | $250.05M(-20.7%) |
| Dec 1994 | $315.33M(+143.2%) | $315.33M(-1.1%) |
| Sep 1994 | - | $318.69M(+27.9%) |
| Jun 1994 | - | $249.07M(+20.0%) |
| Mar 1994 | - | $207.61M(-31.0%) |
| Dec 1993 | - | $300.68M(+118.2%) |
| Sep 1993 | - | $137.80M(+367.1%) |
| Jun 1993 | - | $29.50M(-42.7%) |
| Mar 1993 | - | $51.50M(-55.8%) |
| Dec 1992 | - | $116.60M(+328.7%) |
| Sep 1992 | - | $27.20M(-29.2%) |
| Jun 1992 | - | $38.40M(+70.7%) |
| Mar 1992 | - | $22.50M(-62.7%) |
| Dec 1991 | - | $60.40M(+22.0%) |
| Sep 1991 | - | $49.50M(-14.2%) |
| Jun 1991 | - | $57.70M(+6.3%) |
| Mar 1991 | - | $54.30M(+59.7%) |
| Dec 1990 | - | $34.00M(-71.1%) |
| Sep 1990 | - | $117.50M(+225.5%) |
| Jun 1990 | - | $36.10M(-52.9%) |
| Mar 1990 | - | $76.60M(+463.2%) |
| Dec 1989 | - | $13.60M(-97.7%) |
| Dec 1988 | - | $582.60M(+12.1%) |
| Dec 1987 | - | $519.90M(+8.0%) |
| Dec 1986 | - | $481.60M(+10.1%) |
| Dec 1985 | - | $437.50M(-2.1%) |
| Dec 1984 | - | $447.10M |
| Dec 1981 | $129.68M | - |
FAQ
- What is Abbott Laboratories annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Abbott Laboratories?
- What is Abbott Laboratories annual cash & cash equivalents year-on-year change?
- What is Abbott Laboratories quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Abbott Laboratories?
- What is Abbott Laboratories quarterly cash & cash equivalents year-on-year change?
What is Abbott Laboratories annual cash & cash equivalents?
The current annual cash & cash equivalents of ABT is $7.97B
What is the all time high annual cash & cash equivalents for Abbott Laboratories?
Abbott Laboratories all-time high annual cash & cash equivalents is $18.77B
What is Abbott Laboratories annual cash & cash equivalents year-on-year change?
Over the past year, ABT annual cash & cash equivalents has changed by +$688.00M (+9.45%)
What is Abbott Laboratories quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ABT is $7.28B
What is the all time high quarterly cash & cash equivalents for Abbott Laboratories?
Abbott Laboratories all-time high quarterly cash & cash equivalents is $18.77B
What is Abbott Laboratories quarterly cash & cash equivalents year-on-year change?
Over the past year, ABT quarterly cash & cash equivalents has changed by +$63.00M (+0.87%)